Uncategorized
Department of Defense awards $2.5 million to team consisting of Bozeman’s Microbion Corporation, PENN and UCSF
Published
12 years agoon
Explorebigsky.com Staff Writer
BOZEMAN – $2.5 million in federal grant money may help a Bozeman-based company change the future of the health industry.
Microbion Corporation is developing products related to antibiotic resistant bacteria and microbial biofilms, both in health and industry. Its focus is on an innovative new class of anti-infective drugs, one of the few discovered in the last 30 years.
The funding, awarded to a team consisting of Microbion; University of Pennsylvania; and University of California, San Francisco, will help facilitate Phase 2 human trials to treat post-surgical orthopedic infections with Microbion’s innovative antimicrobial drug, currently in regulatory development. Provided through the U.S. Department of Defense, the grants are part of the 2012 Congressionally Directed Defense Medical Research Program.
Clinical studies will be carried out at both the Hospital of the University of Pennsylvania, and at UCSF/San Francisco General Hospital. A team of researchers led by Samir Mehta, MD, chief of the Orthopaedic Trauma & Fracture Service at the Perelman School of Medicine at the University of Pennsylvania, will work with Microbion and the University of California-San Francisco on the trial, set to begin pending FDA approval of the Investigational New Drug application.
“Orthopaedic trauma and fracture patients are at an increased risk for infection,” Mehta said. “If successful, this new treatment strategy could be a significant step toward reducing instances of amputation, disability and even death.”
This is Microbion’s second DoD grant in support of the regulatory development of this drug. Microbion’s BisEDT therapeutic drug successfully completed Phase 1 human trials in 2011.
“This is an important step for Microbion as we advance this drug to fight extremely challenging infections associated with orthopedic surgeries, including antibiotic resistant infections,” said Dr. Brett Baker, Microbion’s Founder, President and CEO.
In June 2012, the award team met with the FDA in Washington D.C. to discuss Microbion’s plan to advance to Phase 2 human clinical studies for the treatment of post-surgical infections associated with orthopedic medical devices.
In 2011, the World Health Organization identified antibiotic resistance as a global health crisis. aaIn response to this crisis, Congress passed the GAIN (Generating Antibiotic Incentives Now) Act in 2012 with broad bipartisan support. This legislation provides incentives and FDA regulatory priority to companies who are developing new drugs to fight antibiotic resistant infections.
An estimated 100,000 patients receiving orthopedic implants in the U.S. annually suffer from a post-operative infection.
“This is a critically important area for the global community, as almost all current antibiotics are losing effectiveness against resistant bacterial and fungal infections,” Dr. Baker said. “The rapidly expanding unmet need in healthcare is creating an international market that must be addressed as a matter of global necessity. Our technology has the potential to improve outcomes for patients who develop an infection related to an implanted orthopedic medical device.”
Megan Paulson is the Co-Founder and Chief Operating Officer of Outlaw Partners.
Upcoming Events
april, 2024
Event Type :
All
All
Arts
Education
Music
Other
Sports
Event Details
We all are familiar with using a limited palette, but do you use one? Do you know how to use a
more
Event Details
We all are familiar with using a limited palette, but do you use one? Do you know how to use a limited palette to create different color combinations? Are you tired of carrying around 15-20 different tubes when you paint plein air? Have you ever wanted to create a certain “mood” in a painting but failed? Do you create a lot of mud? Do you struggle to achieve color harmony? All these problems are addressed in John’s workbook in clear and concise language!
Based on the bestselling “Limited Palatte, Unlimited Color” workbook written by John Pototschnik, the workshop is run by Maggie Shane and Annie McCoy, accomplished landscape (acrylic) and plein air (oil) artists,exhibitors at the Big Sky Artists’ Studio & Gallery and members of the Big Sky Artists Collective.
Each student will receive a copy of “Limited Palette, Unlimited Color” to keep and take home to continue your limited palette journey. We will show you how to use the color wheel and mix your own clean mixtures to successfully create a mood for your paintings.
Each day, we will create a different limited palette color chart and paint a version of a simple landscape using John’s directives. You will then be able to go home and paint more schemes using the book for guidance.
Workshop is open to painters (oil or acrylic) of any level although students must have some basic knowledge of the medium he or she uses. Students will be provided the book ($92 value), color wheel, value scale and canvas papers to complete the daily exercises.
Sundays, April 14, 21 and 28, 2024
Noon until 6PM.
$170.
Time
14 (Sunday) 12:00 pm - 28 (Sunday) 6:00 pm
Event Details
Trivia from 7 to 9 p.m. at The Waypoint in Town Center. Participation is free, food and beverages available.
Event Details
Trivia from 7 to 9 p.m. at The Waypoint in Town Center. Participation is free, food and beverages available.
Time
(Wednesday) 7:00 pm - 9:00 pm
Location
The Waypoint
50 Ousel Falls Rd